Healthcare Stocks Tech Stocks Technology

Telix Pharmaceuticals (ASX:TLX) Gets FDA Green Light to Resubmit — What Investors Should Know

Telix Pharmaceuticals Gains FDA Clarity on Glioma Imaging Agent Telix Pharmaceuticals (ASX: TLX) has given investors reason to sit up and take notice. The company announced it has reached agreement…

ByCharlie Youlden

02

Sep 2025

Bank Stocks Basic Materials Blue Chip Stocks Consumer Copper Stocks Dividend Stocks Energy Stocks ETF Financials Gold Stocks Healthcare Stocks Industrials Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Mining Stocks Penny Stocks Property Rare Earths Stocks Resources Retail Semiconductor stocks Small Caps Stocks Tech Stocks Technology Uranium Stocks

ASX stocks in America: Here are 4 performing well and 4 performing poorly

You might think ASX stocks in America are doing better than peers which are not there because the USA is a much bigger market. In reality, this is not always…

ByNick Sundich

28

Aug 2025

Healthcare Stocks Market news Tech Stocks

Why Telix (ASX:TLX) Fell 20% After FDA News – And What Investors Should Know

When expectations fall short, sentiment can shift in an instant. That is exactly what happened with Telix Pharmaceuticals (ASX: TLX) after the company received an unexpected setback from…

ByCharlie Youlden

21

Aug 2025

Healthcare Stocks

Is the Market Missing Telix’s Long-Term Potential after 63% Revenue Growth?

Telix Pharmaceuticals: Controversy, Growth, and the Road Ahead Every investor knows the uneasy feeling of watching a stock fall, not because of poor earnings, but because of controversy. That is…

ByCharlie Youlden

18

Aug 2025

Healthcare Stocks International Stocks

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

What does the next few years hold for ASX Health Care Stocks Under Trump? There's no doubt that the health care sector is bearing a greater brunt than any other…

ByNick Sundich

08

Aug 2025

Biotech Stocks Healthcare Stocks Large Caps

Telix SEC Subpoena Explained: Why the Stock Plunged 31%

What Investors Need to Know About the Telix SEC Subpoena What happens when a fast-growing biotech lands a major U.S. listing, then suddenly finds itself in the SEC’s crosshairs? That’s…

ByCharlie Youlden

24

Apr 2025

Healthcare Stocks

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful story? It would have been possible believe back in those…

ByNick Sundich

24

Dec 2024

Blue Chip Stocks

5 ASX stocks with the highest PE multiples and 5 ASX stocks with the lowest PE multiples!

5 ASX stocks with the highest PE multiples Note: All figures are in AUD and for FY25 unless otherwise stated Polynovo (ASX:PNV) - 154x (Share price of $2.12 vs EPS of…

ByNick Sundich

19

Nov 2024

General

4 of the best ASX IPOs in the last decade!

In this article, we recap the best ASX IPOs in the last decade. Investing in IPOs is a big risk because there is no guarantee things will go well. It is…

ByNick Sundich

09

Oct 2023

Healthcare Stocks

FDA approval: Here’s how ASX biotechs and medtechs obtain it

Last week one of our favourite companies Cyclopharm (ASX:CYC) obtained FDA approval, a goal it had been striving for years to obtain and one that wasn't reached without setbacks along…

ByNick Sundich

Telix Pharmaceuticals (ASX:TLX) Gets FDA Green Light to Resubmit — What Investors Should Know

ASX stocks in America: Here are 4 performing well and 4 performing poorly

Why Telix (ASX:TLX) Fell 20% After FDA News – And What Investors Should Know

Is the Market Missing Telix’s Long-Term Potential after 63% Revenue Growth?

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

Telix SEC Subpoena Explained: Why the Stock Plunged 31%

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

5 ASX stocks with the highest PE multiples and 5 ASX stocks with the lowest PE multiples!

4 of the best ASX IPOs in the last decade!

FDA approval: Here’s how ASX biotechs and medtechs obtain it

PLS Group (ASX:PLS) Hits Record High on...

Narryer Metals (ASX:NYM) Tim Goyder Back...

Sovereign Metals (ASX:SVM) DFS lands,$2....

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here